How do unfractionated and low-molecular-weight heparin compare after ST-segment elevation MI?

Abstract

DESIGN AND INTERVENTION In this meta-analysis, Eikelboom et al. analyzed data from eligible randomized trials that compared intravenous UFH with subcutaneous LMWH, and from trials of intravenous UFH or subcutaneous LMWH that were either placebocontrolled or included an untreated group of control patients for comparison. To be eligible, trials had to analyze patients with STEMI who had been treated with aspirin and thrombolytic therapy, and to have recorded reinfarction and mortality as outcome measures.

DOI: 10.1038/ncpcardio0559

Cite this paper

@article{Lincoff2006HowDU, title={How do unfractionated and low-molecular-weight heparin compare after ST-segment elevation MI?}, author={A. Michael Lincoff}, journal={Nature Clinical Practice Cardiovascular Medicine}, year={2006}, volume={3}, pages={300-301} }